Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer

By Blana Andreas   Rogenhofer Sebastian   Ganzer Roman   Wild Peter   Wieland Wolf   Walter Bernhard  

World Journal of Urology, Vol. 24, Iss. 5, 2006-11 ,pp. : 585-590

Springer Publishing Company

Access to resources Recommend Favorite

Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma

By Beerlage H.P.   Thuroff S.   Debruyne F.M.J.   Chaussy C.   de la Rosette J.J.M.C.H.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 273-277

Elsevier

Access to resources Recommend Favorite

Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy

By Cadeddu J.A.   Partin A.W.   Epstein J.I.   Walsh P.C.  

Urology, Vol. 50, Iss. 2, 1997-08 ,pp. : 251-255

Elsevier

Access to resources Recommend Favorite

Transrectal focused ultrasound (HIFU) in prostate cancer

By Thuroff S.   Chaussy G.   Kiel H.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 135-135

Elsevier

Access to resources Recommend Favorite

A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: Early results

By Berge Viktor   Baco Eduard   Karlsen Steinar Johan  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 4, 2010-09 ,pp. : 223-227

Informa Healthcare

Access to resources Recommend Favorite